This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 5005120

PUBLISHED SUBJECT

Imunoglobulina humana normal 100 mg/ml Sol inj Fr 200 ml IV Adalimumab 40 mg/0.4 ml Sol inj Caneta 0.4 ml SC Emtricitabina 200 mg + Tenofovir alafenamida 10 mg Comp Emtricitabina 200 mg + Tenofovir alafenamida 25 mg Comp ENZALUTAMIDA 40 MG Sorafenib 200 mg Comp SUNITINIB 12,5MG COMP VALGANCICLOVIR 450 MG, COMP

Parties involved

Place of performance
Portugal, Setúbal, Setúbal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
GILEAD SCIENCES · Tax ID 503604704
Awardee
BAYER PORTUGAL, SA. · Tax ID 500043256
Awardee
ABBVIE, LDA. · Tax ID 510229050
Awardee
TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
Awardee
ASTELLAS FARMA LDA · Tax ID 502540249

Values and timeline

Contract price
€116,553.65
Procedure base price
€116,553.65
Total effective price
Not reported on Portal BASE
Publication date
3 December 2018
Award date
21 November 2018
Signing date
21 November 2018
Performance period
10 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2017/9 - Acordo quadro para fornecimento de Derivados do Plasma Humano às Instituições e Serviços do Serviço Nacional de Saúde
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
3706615

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts